Terada T, Inui K. Peptide transporters. structure, function, regulation and application for drug delivery[J]. Curr Drug Metab, 2004, 5(1): 85- 94.
[2]
Schluesener HJ, Tan X. Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in vivo display[J]. J Neurol Sci, 2004, 224(1-2): 77-82.
[3]
Reiersen H, Berntsen G, StassarM, et al. Screening human antibody libraries against carcinoma cells by affinity purification and polymerase chain reaction[J]. J Immunol Methods, 2008, 330(1-2): 44-56.
[4]
Williams B, Atkins A, Zhang H, et al. Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth[J]. Leukemia, 2005, 19(8): 1432-1438.
[5]
Bakker AB, van den Oudenrijn S, BakkerA Q, et al. C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia[J]. Cancer Res, 2004, 64(22): 8443-8450.
[6]
Akman FC, Dag N, Ataman OU, et al. The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy [J]. Eur Arch Otorhinolaryngol 2008, 265(10): 1245-1255.
[7]
Smith RB. Surgery in the management of laryngeal and hypopharyngeal carcinoma [J]. Int J Radiat Oncol, 2007, 69(Suppl 2): 28-30.
Smith GP. Filamentous fusion phage. novel expression vectors that display cloned antigens on the virion surface[J]. Science, 1985, 228(4705): 1315-1317.
[10]
Parmley SF, Smith GP. Antibody-selectable filamentous phage vectors. affinity purification of target genes[J]. Gene, 1988, 73(2): 305-318.
[11]
David NK, Girja SS, Shen GP, et al. Selection of Tumor-binding Ligands in Cancer Patients with Phage Display Libraries[J]. Cancer Res, 2006, 66(15): 7724-7733.
Bing Yu, Ming Ni, Wen-Han Li, et al. Human scFv antibody fragments specific for hepatocellular carcinoma selected from a phage display library[J]. World J Gastroenterol, 2005, 11(26): 3985-3989.
[14]
Lee TY, Wu HC, Tseng YL, et al. A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery[J]. Cancer Res, 2004, 64(21): 8002-8008.
[15]
Geuijen CA, BijlN, Smit RC, et al. A proteomic approach to tumor target identification using phage display, affinity purification and mass spectrometry[J]. Eur J Cancer, 2005, 41(1): 178-187.
